Chad Pecot, MD, associate professor of medicine and member of the UNC Lineberger Comprehensive Cancer Center, will lead the new center dedicated to the investigation of the many roles of…
May 4, 2022
UNC Children’s renamed its hematology/oncology clinic The Reelin’ for Research Pediatric Hematology Oncology Clinic in honor of the organization that donated $800,000 this week and more than $5 million since…
May 3, 2022
Jenny Ting, PhD, the William Kenan Distinguished Professor of Genetics, and Ralph Baric, PhD, the William Kenan Distinguished Professor of Epidemiology and Microbiology & Immunology, were elected as members of…
April 19, 2022
This virtual seminar series will provide a background in the use of machine learning tools to answer clinical questions, understand the strengths and limitations of these methods, and examine real-world…
April 11, 2022
Study Finds Intervention Improved Rates of Tobacco Screening, Cessation Support in Small North Carolina Practices
Sarah Kowitt, PhD, MPH, Adam Goldstein, MD, MPH, and Samuel Cykert, MD, recently published a study that found a cardiovascular disease risk reduction intervention improved rates of tobacco screening and…
March 24, 2022
Researchers led by Yevgeny Brudno, PhD, in the UNC-NCSU Joint Biomedical Engineering Department, have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.
March 8, 2022
UNC Health will partner with Philips to implement evidence-based treatment paths using Philips Oncology Pathways software, a new clinical tool to help doctors match patients with the best possible chemotherapy…
March 1, 2022
The Translational Team Science Awards program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators.
February 11, 2022
Paola A. Gehrig, MD, will begin her new role on June 27. She completed her residency in obstetrics and gynecology at the University of Virginia.
January 26, 2022
This research, led by Jean Cook, PhD, and Liu Mei, PhD, at the UNC School of Medicine, may help explain why certain parts of the genome become highly mutable in…
January 25, 2022
The record-setting gift supports development of innovative cancer treatments, eradicating health disparities. The center’s inaugural director is Lisa Carey, PhD, the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast…
January 20, 2022
The UNC Medical Center is the only organization in North Carolina accredited by the Commission on Cancer’s National Accreditation Program for Rectal Cancer.
December 23, 2021
Jenny Ting, PhD, is the recipient of the Illinois State University Distinguished Alumni Award for her outstanding immunology research.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious…
Announcements, Awards, Rankings and Recognitions, Bioinformatics, Cancer, Clinical Research, Covid-19 / Coronavirus, Diversity, Equity and Inclusion, Education, Events, Faculty, General Medicine, Global Health, Health Sciences, Infectious Diseases, Neurology, News, North Carolina, Oncology, Physical Medicine & Rehabilitation, Physical Therapy, Pulmonology, Research, School of Medicine, Technology and Innovation, UNC Health, Vital Signs, Wellness
October 6, 2021
$1 Million gift furthers landmark study focused on reducing breast cancer disparities, barriers to high quality care
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study.
September 29, 2021
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.
September 23, 2021
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
September 14, 2021
The UNC Lineberger Developmental Funding Program supports the development of cancer research led by faculty to stimulate new applications for extramural funding. All UNC Lineberger Comprehensive Cancer Center members, UNC-Chapel…
August 4, 2021
Tonia Poteat, PhD, MPH, a core member of the Center for Health Equity Research, and colleagues published research on delays in breast cancer care by race and sexual orientation.
July 12, 2021
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.